Pancreatoduodenectomy (PD) offers the only option for cure in resectable, nonmetastatic pancreatic and periampullary cancer [1]. However, PD is technically challenging and fraught with a significant risk of morbidity and even mortality [2]. Obstructive jaundice is one of the most common symptoms of pancreatic and periampullary cancer [3]. Hyperbilirubinaemia has been recognised as contributory ...

A pancreatic sarcoma of nerve sheath origin is reported in a 28-year-old female patient, who presented with melaena. Preoperative imaging showed an 8.5 cm diameter mass in the head of pancreas. There was bleeding from the papilla of Vater at endoscopy and a highly vascular lesion on arteriography. The patient was submitted to proximal pancreatoduodenectomy and remains symptom-free at 1 year fol...

Maxat DOSKHANOV, Bolatbek BAIMAKHANOV, Daniyar MUKAZHANOV, Serik TILEUOV*, Shokan KANIEV, Manas SEISEMBAYEV, Almat CHORMANOV, Erbol SERIKULY, Abzal ISMATOV, Baglan ASKEEV, Aidar SKAKBAYEV, Aziza KHAJIYEVA, Zhambyl OSPAN, Shakhmurat TEIPOV, Mazdak ASAN. Ann Hepatobiliary Pancreat Surg 2023;27:S405. https://doi.org/10.14701/ahbps.2023S1.EP-139

Carcinoid tumors of ampulla are rare clinical entities. They form 0.35% of all the gastrointestinal carcinoids. So far, only 109 cases have been reported in the literature, mostly as individual case reports. Since the metastatic potential and the tumor size have no correlation, unlike in duodenal carcinoids, pancreatoduodenectomy is considered the treatment of choice. Here we present a case of ...

A 32-year-old woman with a choledochal cyst (Todani type I) developed recurrent acute pancreatitis leading to calcific chronic pancreatitis. She had previously been treated with two cyst drainage procedures and subtotal cyst excision. This association between choledochal cyst and chronic pancreatitis has not been previously reported. Severe continuing symptoms led to pylorus-preserving proximal...

Presenter: Fabio Makdissi MD | Nove de Julho Hospital Background: Surgical resection along with adjuvant or neoadjuvant chemotherapy is the only curative modality for treatment of patients pancreatic and periampullary tumors. With increasing use minimally invasive techniques, laparoscopic robotic pancreatoduodenectomy (PD) has become more common, but artery-first techniques have been described ...